Brief: NeuroVive Receives Vinnova Funding

Abliva AB

15/11/2018 11:02

Nov 15 (Reuters) - NeuroVive Pharmaceutical AB  NVP.ST :
    * NEUROVIVE RECEIVES VINNOVA FUNDING TO SUPPORT DEVELOPMENT
OF
NV354, A NOVEL TREATMENT FOR GENETIC MITOCHONDRIAL DISORDERS
    * HAS BEEN AWARDED SEK 1.5 MILLION AS A FIRST TRANCHE OF
TOTAL SEK
5 MILLION IN FUNDING FROM VINNOVA

Source text for Eikon:  ID:nWkr7L4Gzj 
Further company coverage:  NVP.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))